Baclofen Tablets USP recall — Class II (D-0235-2026) · pharmaranks
Class IIOngoing
Baclofen Tablets USP recall
FDA recall D-0235-2026 · initiated Nov 26, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of Foreign Tablets/Capsules
Details
Product
Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10
Recalling company
Golden State Medical Supply Inc.
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide within the USA
Initiated
Nov 26, 2025
FDA report date
Dec 24, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.